Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics
Lantheus Holdings, Inc. (LNTH)
Today's Latest Price: $15.96 USD
Updated Jan 22 6:55pm
Add LNTH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
LNTH Stock Summary
- With a price/earnings ratio of 2,743.62, Lantheus Holdings Inc P/E ratio is greater than that of about 99.58% of stocks in our set with positive earnings.
- The price/operating cash flow metric for Lantheus Holdings Inc is higher than 82.33% of stocks in our set with a positive cash flow.
- The volatility of Lantheus Holdings Inc's share price is greater than that of merely 14.44% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Lantheus Holdings Inc are MSTR, CYBR, HQY, JVA, and SGH.
- LNTH's SEC filings can be seen here. And to visit Lantheus Holdings Inc's official web site, go to www.lantheus.com.
LNTH Stock Price Chart Interactive Chart >
LNTH Price/Volume Stats
| Current price | $15.96 | 52-week high | $19.20 |
| Prev. close | $15.40 | 52-week low | $8.67 |
| Day low | $15.27 | Volume | 526,600 |
| Day high | $16.00 | Avg. volume | 504,893 |
| 50-day MA | $14.01 | Dividend yield | N/A |
| 200-day MA | $13.52 | Market Cap | 1.07B |
Lantheus Holdings, Inc. (LNTH) Company Bio
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company was founded in 1956 and is based in North Billerica, Massachusetts.
LNTH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $15.96 | $6.17 | -61% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Lantheus Holdings Inc. To summarize, we found that Lantheus Holdings Inc ranked in the 30th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 61.17%. In terms of the factors that were most noteworthy in this DCF analysis for LNTH, they are:
- Lantheus Holdings Inc's effective tax rate, as measured by taxes paid relative to net income, is at 163 -- greater than 98.59% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 11. This value is greater than 83.88% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -62% |
| 1% | -62% |
| 2% | -61% |
| 3% | -61% |
| 4% | -61% |
| 5% | -60% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as LNTH, try HOLX, ICLR, HAPP, JNJ, and VIVO.
Loading social stream, please wait...